XML 45 R21.htm IDEA: XBRL DOCUMENT v3.23.2
Issued share capital, share premium account and share options
12 Months Ended
Mar. 31, 2023
Issued share capital, share premium account and share options  
Issued share capital, share premium account and share options

14.         Issued share capital, share premium account and share options

(a)Share capital

At March 31, 

    

2023

    

2022

    

2021

 

€M

 

€M

 

€M

Authorized/Share Capital reorganization

1,550,000,000 ordinary equity shares of 0.600 euro cent each

 

9.3

 

9.3

 

9.8

1,368,000,000 'B' Shares of 0.050 euro cent each

 

0.7

 

0.7

 

0.7

1,368,000,000 Deferred shares of 0.050 euro cent each

 

0.7

 

0.7

 

0.7

 

10.7

 

10.7

11.2

Allotted, called-up and partly paid:

1,128,062,028 ordinary equity shares of 0.600 euro cent each

 

 

 

6.7

1,134,528,528 ordinary equity shares of 0.600 euro cent each

 

 

6.8

 

1,138,674,528 ordinary equity shares of 0.600 euro cent each

6.9

Movements in the share capital balance year-on-year principally relates to 4.1m new shares issued in fiscal year 2023, following the exercise of share options, (2022: 6.5m; 2021: 3.6m). There were no share buybacks, resulting in no cancelled shares, in fiscal year 2023 (2022: nil; 2021: nil).

Ordinary equity shares do not confer on the holders thereof the specific right to be paid a dividend out of profits.

(b)Share premium account

At March 31, 

    

2023

    

2022

    

2021

 

€M

 

€M

 

€M

Balance at beginning of year

 

1,328.2

 

1,161.6

 

738.5

Net proceeds from shares issued

31.7

46.8

423.1

Share premium receivable on shares issued

20.0

119.8

Balance at end of year

 

1,379.9

 

1,328.2

 

1,161.6

(c)Share options and share purchase arrangements

Option Plan 2013 allows employees or Directors to purchase shares in the Company up to an aggregate of approximately 5% (when aggregated with other ordinary shares over which options are granted and which have not yet been exercised) of the outstanding ordinary shares of Ryanair Holdings plc, subject to certain conditions. All grants are subject to approval by the Remuneration Committee. These are exercisable at a price equal to the market price of the ordinary shares at the time options are granted. The key terms of these option plans include the requirement that certain employees remain in employment with the Company for a specified period of time and that the Company achieves certain net profit targets and/or share price targets. At the 2019 AGM, shareholders approved LTIP 2019. LTIP 2019 replaces Option Plan 2013 for all future share based remuneration grants. There were approximately 0.9m cumulative conditional ordinary shares granted under LTIP 2019 at March 31, 2023.

Details of the share options outstanding are set out below:

Share

Weighted Avg.

    

Options

    

Exercise

     

M

     

Price (€)

Outstanding at March 31, 2020

 

34.8

9.57

Granted

 

Forfeited

 

(1.2)

11.56

Exercised

(3.6)

6.42

Outstanding at March 31, 2021

 

30.0

9.83

Granted

 

Forfeited

(0.7)

12.98

Exercised

 

(6.5)

7.23

Outstanding at March 31, 2022

 

22.8

10.57

Granted

Forfeited

Exercised

(4.1)

7.64

Outstanding at March 31, 2023

 

18.7

11.24

The mid-market price of Ryanair Holdings plc’s ordinary shares on Euronext Dublin at March 31, 2023 was €14.95 (2022: €13.59; 2021: €16.55). The highest and lowest prices at which the Company’s shares traded on Euronext Dublin in fiscal year 2023 were €15.76 and €10.09 respectively (fiscal year 2022 were €18.45 and €11.83 respectively; fiscal year 2021 were €17.56 and €8.20 respectively). There were 1.7m options exercisable at March 31, 2023 (2022: 4.3m; 2021: 10.9m). The average share price for fiscal year 2023 was €13.20 (2022: €16.08; 2021: €13.01).

There were 4.1m options exercised during fiscal year 2023 (2022: 6.5m; 2021: 3.6m).

At March 31, 2023 the range of exercise prices and weighted average remaining contractual life of outstanding options are shown in the table below.

No.

Remaining

Exercise

options

contractual

price

outstanding

life

M

     

(years)

Vested

6.25

 

Vested

6.74

Vested

8.35

11.12

17.0

3.9

Vested

12.00

1.6

1.4

Vested

14.40

0.1

1.4

Vested

17.55

Weighted average

11.24

18.7

3.67

The Company has accounted for its share option and LTIP grants to employees at fair value, in accordance with IFRS 2, using a binomial lattice model to value the option grants. This has resulted in a charge of approximately €16m to the income statement (2022: €9m; 2021: €4m) being recognized within the income statement in accordance with employee services rendered.

A blend of the historical and implied volatilities of the Company’s own ordinary shares is used to determine expected volatility for share options granted. The weighted-average volatility is determined by calculating the weighted-average of volatilities for all share options granted in a given year. The expected term of share option grants represents

the weighted-average period the awards are expected to remain outstanding. The service period is five years in relation to share options and three years in relation to LTIP conditional share grants.